ask="2.15"
ask_size="700"
average_daily_volume="49539"
bid="1.80"
bid_size="2000"
book_value="0.81"
change="-0.04"
change_from_200_day_moving_average="0.25"
change_from_50_day_moving_average="0.27"
change_from_52_week_high="-1.72"
change_From_52_week_low="0.74"
change_in_percent="-2.00%"
close="1.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="2.06"
high_52_weeks="3.68"
last_trade_date="2/21/2017"
last_trade_price="1.96"
last_trade_size="110"
last_trade_time="4:00pm"
low="1.91"
low_52_weeks="1.22"
market_capitalization="21.53M"
moving_average_200_day="1.71"
moving_average_50_day="1.69"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="2.06"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+14.79%"
percent_change_from_50_day_moving_average="+15.90%"
percent_change_from_52_week_high="-46.74%"
percent_change_from_52_week_low="+60.66%"
previous_close="2.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.47"
price_per_sales="5.79"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.62"
stock_exchange="NCM"
symbol="CBLI"
volume="45394"
weeks_range_52="1.22 - 3.68"
